Nexalin Technology: A Leader in Neurostimulation for Addiction
Nexalin Technology, Inc. (Nasdaq: NXL) is making significant strides in the realm of mental health treatment. The company has announced promising results from a recent study highlighting its 15 milliamp neurostimulation device's effectiveness in treating gambling disorder with alcohol use comorbidity. This breakthrough development underscores the potential for non-invasive therapies to address complex addiction issues.
Independent Study Showcases Remarkable Results
The findings come from a peer-reviewed study published in The American Journal on Addictions. This publication highlights a case where a patient diagnosed with both gambling disorder and alcohol use disorder underwent treatment using Nexalin’s neurostimulation device. The treatment regimen consisted of 20 outpatient sessions over a span of 10 days.
Significant Improvement and Patient Outcomes
Remarkably, the patient achieved complete abstinence from gambling and alcohol after completing the treatment sessions. Not only was abstinence maintained, but there were also noted improvements in cognitive control and no adverse side effects recorded during a three-month follow-up. This level of success indicates the potential of Nexalin's device to effect genuine change in patients struggling with multiple addictions.
Scientifically Validated Approach to Therapy
The authors of the study have emphasized that Nexalin’s device is a safe and effective potential treatment for individuals experiencing gambling disorder alongside alcohol use disorders. It marks a significant milestone as it is the first published clinical application of this neurostimulation technology for patients with dual diagnoses.
Understanding the Mechanism of Action
Researchers observed that cognitive improvements tended to occur before sustained behavioral changes. This suggests that the neuroplasticity involved—possibly through modulation of deeper brain networks—plays a crucial role in recovery from addiction. The device utilized in the study operated at 15 mA delivered at 77.5 Hz for a duration of 40 minutes per session.
Commitment to Breakthrough Therapeutics
Mark White, CEO of Nexalin Technology, expressed confidence in the growing scientific validation of their device as a non-pharmacological treatment option for addiction. He stated, "These results highlight how Nexalin's frequency-based neurostimulation represents a breakthrough in non-invasive stimulation of the brain." White's commitment to advancing global research further emphasizes the potential of Nexalin’s technology to revolutionize mental health treatment.
Looking Ahead: The Future of Treatment Options
Concluding the study, the authors called for larger, controlled trials to further explore the effectiveness of Nexalin’s 15 mA device. Such research is crucial for verifying the initial findings and expanding therapeutic options for patients grappling with addiction comorbidities and various psychiatric disorders.
An Overview of Nexalin Technology
Nexalin is dedicated to designing and developing pioneering neurostimulation products aimed at combating the escalating mental health crisis globally. The company’s products are known for being non-invasive and undetectable, providing hope and relief to those affected by mental health issues. Research suggests that Nexalin's technology can penetrate deep into the mid-brain structures linked with mental health disorders—representing a significant advance in treatment approaches.
Global Impact and Future Prospects
With approvals in multiple countries, including China, Brazil, and Oman, Nexalin's Gen-2 and Gen-3 devices are leading the charge toward enhanced treatment efficacy without adverse effects. This broader reach indicates a commitment to making innovative therapy accessible worldwide.
Frequently Asked Questions
What is Nexalin Technology known for?
Nexalin Technology, Inc. specializes in developing non-invasive neurostimulation products designed to treat mental health disorders.
What were the results of the recent study?
The study reported complete abstinence from gambling and alcohol for the patient after treatment, with marked improvements in cognitive function.
How does Nexalin’s neurostimulation device work?
The device applies a mild neurostimulation technique utilizing a specific electrical waveform to modulate brain activity associated with addiction.
What is the significance of this study for addiction treatment?
The study is the first to demonstrate successful clinical application of Nexalin's device for patients with gambling and alcohol use disorders, paving the way for further research and development.
Where can I find more information about Nexalin?
More detailed information can be found on Nexalin’s official website, where updates and insights about their ongoing research and technological advancements are regularly posted.
